What does registration cost?

From September 26, 2026 (on-site rates), Full Conference registration is $1,705 for members and $2,145 for non-members; a 1-day pass (Mon/Tue/Wed) is $825 for members and $1,072 for non-members; student/post-doc registration is $325 with membership. Lower early and advance rates applied until September 25.

Is there a pass for the exhibit hall only?

Yes. The Exhibits & Networking Pass covers the exhibit hall, the Welcome and Closing Receptions, and Posters & Career Development: $440 for all three days or $259 for one day at the on-site rate.

What does Full Conference registration include?

Access to the scientific sessions, the Solution Center (exhibit hall), and the Welcome and Closing Receptions.

Where is the headquarters hotel?

Hilton New Orleans Riverside, 2 Poydras St, is the HQ hotel, with an AAPS rate of $289 per night plus tax; several other nearby hotels also have AAPS rates.

AAPS 2026 PharmSci 360

Name: AAPS 2026 PharmSci 360
Start: 2026-10-25T09:00:00+00:00
End: 2026-10-28T17:00:00+00:00
Location: Ernest N. Morial Convention Center

About this event

PharmSci 360 is the annual meeting of the American Association of Pharmaceutical Scientists (AAPS), which convenes thousands of scientists from across the drug development process. AAPS describes it as combining the scale of a large scientific conference with the focus of a niche meeting: the programme is built on tracks that follow the development pipeline, so attendees can stay in one track or move between them. The 2026 edition takes place in New Orleans.

Scientific tracks

Each track is organised around three themes set by the 2026 Scientific Programming Committee, chaired by Parag Kolhe of Pfizer.

Preclinical, Clinical and Translational Sciences: in vitro and in silico modeling, PBPK and QSP, NAMs and organ-on-a-chip, MIDD, real-world data and AI/ML
Bioanalytics: assay qualification under evolving guidance, emerging modalities such as cell and gene therapies, patient-centric sampling and automation
Manufacturing and Analytical Characterization: ADCs, LNPs, continuous manufacturing, PAT, digital twins and next-generation characterization
Formulation and Delivery: AI-guided formulation, novel excipients and delivery platforms, patient-centric product design and drug-device combinations
Career Development: a Professional Advancement track on job-seeking skills, the business of science and career strategy

Solution Center

The Solution Center is the exhibit hall, where suppliers, CROs, CDMOs and technology providers meet attendees. It is included in Full Conference registration, and a cheaper Exhibits & Networking Pass covers the hall, posters, career development and the Welcome and Closing Receptions.

Who attends

Pharmaceutical scientists from industry, academia and regulatory agencies working in discovery, preclinical and clinical pharmacology, bioanalysis, CMC, manufacturing, formulation and drug delivery, plus students and post-docs building their careers.

Tickets & passes

Full Conference – Member — USD 1,705: On-site rate from Sept 26 (early $1,265, advance $1,485)
Full Conference – Non-member — USD 2,145: On-site rate from Sept 26 (early $1,705, advance $1,925)
1-Day Pass – Member — USD 825: Mon, Tue or Wed; on-site rate
1-Day Pass – Non-member — USD 1,072: Mon, Tue or Wed; on-site rate
Student/Post-Doc — USD 325: Membership required; on-site rate
Exhibits & Networking Pass – 3 days — USD 440: Exhibit hall, receptions, posters and career development; on-site rate
Exhibits & Networking Pass – 1 day — USD 259: On-site rate

AAPS 2026 PharmSci 360 was a Healthcare event that took place 25-28 Oct 2026 at Ernest N. Morial Convention Center, New Orleans, United States.

Event recap

AAPS PharmSci 360 2026, the annual meeting of the American Association of Pharmaceutical Scientists, took place from 25 to 28 October at the Ernest N. Morial Convention Center in New Orleans. The meeting combined a scientific programme with an exhibition for pharmaceutical development, manufacturing and analytical science. Announcements made during the meeting included the launch of Humanitas Global Health, which licensed Louisiana State University's DeepDrug AI technology, and Dong-A ST's presentation of preclinical findings on a topical icotrokinra formulation for psoriasis.